While stressing that the country has tackled the Covid-19 situation extremely well she said, “Another thing to keep in mind is that if 100 people are affected by the virus, then 85 people are cured without going to the hospital. In India, the death rate is decreasing very fast, it means that the health care systems are working very well,” added Reddy.
While praising the pharmaceutical companies in India, she added, they must further strengthen its capabilities. “Four pharma companies in India are licensing from Gilead Sciences for manufacturing the drug. Drugs like Remidivisir should be looked upon as a hope-clinical trial of this is going on. We need to understand the virus is very new and we are looking for ways to combat it,” she added.
Also Watch: Health insurances should be made mandatory for all: JMD Apollo Sangita Reddy | Full Interview
On asked that India is exporting drugs to the whole world, and the promise in Remidivisir drug trial she said, “In India already four companies are making Remidivisir. We don’t depend on other countries. We will also export it to other countries”
She is hopeful of the health budget to get more than doubled in the future as she praised India for handling the Covid-19 cases so well and keeping the death rates low compared to other nations. Everyone is now mulling at increasing the health care budget and the preparedness to deal with the pandemic of such intensity.
It is the responsibility of the entire society to fight coronavirus and not an individual’s fight or a particular segment of society.